-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
May 01, 2013 - to coronary artery disease and
shares similar risk factors: male gender,
age, diabetes, smoking, hypertension … inhibitors and the management of other risk
factors such as tobacco use, diabetes, LDL levels, and
hypertension … diabetes (two
studies), and one study each on smoking status, vessel
patency, sex, hyperlipidemia, hypertension … , when more effective medical
treatments such as statins, ACE inhibitors, and adequate
control of hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core_Weighted.PDF
January 01, 2018 - 27,810 0.08%
302: ATHEROSCLEROSIS W MCC 8,315 0.02%
303: ATHEROSCLEROSIS W/O MCC 35,935 0.10%
304: HYPERTENSION … W MCC 41,155 0.12%
305: HYPERTENSION W/O MCC 99,650 0.28%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core.PDF
January 01, 2018 - 5,562 0.08%
302: ATHEROSCLEROSIS W MCC 1,663 0.02%
303: ATHEROSCLEROSIS W/O MCC 7,187 0.10%
304: HYPERTENSION … W MCC 8,231 0.12%
305: HYPERTENSION W/O MCC 19,930 0.28%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
January 01, 2019 - 25,855 0.07%
302: ATHEROSCLEROSIS W MCC 7,905 0.02%
303: ATHEROSCLEROSIS W/O MCC 33,140 0.09%
304: HYPERTENSION … W MCC 42,325 0.12%
305: HYPERTENSION W/O MCC 102,875 0.29%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core_Weighted.PDF
January 01, 2017 - 31,190 0.09%
302: ATHEROSCLEROSIS W MCC 8,306 0.02%
303: ATHEROSCLEROSIS W/O MCC 36,894 0.10%
304: HYPERTENSION … W MCC 37,983 0.11%
305: HYPERTENSION W/O MCC 103,597 0.29%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core_Weighted.PDF
January 01, 2016 - 35,152 0.10%
302: ATHEROSCLEROSIS W MCC 8,364 0.02%
303: ATHEROSCLEROSIS W/O MCC 39,173 0.11%
304: HYPERTENSION … W MCC 15,157 0.04%
305: HYPERTENSION W/O MCC 78,245 0.22%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core_Weighted.PDF
January 01, 2018 - 27,331 0.08%
302: ATHEROSCLEROSIS W MCC 7,781 0.02%
303: ATHEROSCLEROSIS W/O MCC 34,166 0.10%
304: HYPERTENSION … W MCC 41,485 0.12%
305: HYPERTENSION W/O MCC 103,919 0.29%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
January 01, 2019 - .**%
303: ATHEROSCLEROSIS W/O MCC 94 0.00%
304: HYPERTENSION W MCC 448 0.01%
305: HYPERTENSION W/O
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core_Weighted.PDF
January 01, 2016 - .**%
303: ATHEROSCLEROSIS W/O MCC 88 0.00%
304: HYPERTENSION W MCC 193 0.00%
305: HYPERTENSION W/O
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-1.pdf
January 31, 2024 - Walunas (NU), as well as subject matter experts on hypertension and tobacco cessation
representing the … net practices to
improve blood pressure control and reduce heart health disparities by implementing hypertension … CardiOH lead CWRU has also worked to address
hypertension through QI initiatives with eight high-volume … providers Qsource
Cooperative focus
Implementation of heart health interventions with a focus on hypertension … HHOI’s value proposition to practices and providers highlighted the high number of people with
hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
September 15, 2014 - Page 255 It appears that this update found no new
studies on the combined effect of vitamin D and
hypertension … These bone-related sections are separated by sections
on non-bone related outcomes (mortality, and
hypertension … It is not clear why the
bone-related variables were separated in this manner,
especially since hypertension
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017035-mehr-final-report-2011.pdf
January 01, 2011 - reports were planned for several chronic conditions, including also coronary artery
disease (CAD), hypertension … clinics were identified by reports generated from
the EMR every two weeks with established diabetes and hypertension … study of
remote electronic monitoring entirely concerned chronically ill patients with diabetes and
hypertension
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core.PDF
January 01, 2021 - 0.06%
302: ATHEROSCLEROSIS WITH MCC 1,308 0.02%
303: ATHEROSCLEROSIS WITHOUT MCC 5,070 0.08%
304: HYPERTENSION … WITH MCC 8,060 0.12%
305: HYPERTENSION WITHOUT MCC 16,810 0.25%
306: CARDIAC CONGENITAL AND VALVULAR
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_V2.PDF
January 01, 2020 - 0.06%
302: ATHEROSCLEROSIS WITH MCC 1,301 0.02%
303: ATHEROSCLEROSIS WITHOUT MCC 5,101 0.08%
304: HYPERTENSION … WITH MCC 7,580 0.12%
305: HYPERTENSION WITHOUT MCC 16,342 0.25%
306: CARDIAC CONGENITAL AND VALVULAR
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core.PDF
January 01, 2022 - 0.06%
302: ATHEROSCLEROSIS WITH MCC 1,354 0.02%
303: ATHEROSCLEROSIS WITHOUT MCC 4,870 0.07%
304: HYPERTENSION … WITH MCC 8,508 0.13%
305: HYPERTENSION WITHOUT MCC 17,197 0.26%
306: CARDIAC CONGENITAL AND VALVULAR
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
January 01, 2019 - 25,025 0.07%
302: ATHEROSCLEROSIS W MCC 7,263 0.02%
303: ATHEROSCLEROSIS W/O MCC 31,693 0.09%
304: HYPERTENSION … W MCC 43,198 0.12%
305: HYPERTENSION W/O MCC 107,332 0.30%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_CORE.PDF
January 01, 2021 - 0.06%
302: ATHEROSCLEROSIS WITH MCC 3,535 0.02%
303: ATHEROSCLEROSIS WITHOUT MCC 13,926 0.08%
304: HYPERTENSION … WITH MCC 22,076 0.13%
305: HYPERTENSION WITHOUT MCC 47,565 0.28%
306: CARDIAC CONGENITAL AND VALVULAR
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
January 01, 2018 - 15,023 0.08%
302: ATHEROSCLEROSIS W MCC 4,238 0.02%
303: ATHEROSCLEROSIS W/O MCC 18,997 0.11%
304: HYPERTENSION … W MCC 22,377 0.13%
305: HYPERTENSION W/O MCC 56,324 0.32%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
January 01, 2019 - CC/MCC 442 0.01%
302: ATHEROSCLEROSIS W MCC 32 0.00%
303: ATHEROSCLEROSIS W/O MCC 70 0.00%
304: HYPERTENSION … W MCC 334 0.01%
305: HYPERTENSION W/O MCC 782 0.03%
306: CARDIAC CONGENITAL & VALVULAR DISORDERS W
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2022_MaskedStats_Core_Weighted.PDF
January 01, 2022 - .**%
303: ATHEROSCLEROSIS WITHOUT MCC 64 0.00%
304: HYPERTENSION WITH MCC 499 0.01%
305: HYPERTENSION